| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | CA2446904A1 Delivery of drug esters through an inhalation route |
| 04/03/2003 | CA2424057A1 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones |
| 04/02/2003 | EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes |
| 04/02/2003 | EP1298127A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen |
| 04/02/2003 | EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 04/02/2003 | EP1296997A1 Base analogues |
| 04/02/2003 | EP1296986A1 5-aminoalkyl-pyrazolo 4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 04/02/2003 | EP1296985A2 Heteropolycyclic inhibitors |
| 04/02/2003 | EP1296984A1 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 04/02/2003 | EP1296983A1 Novel process for the preparation of pyrazolopyrimidinones |
| 04/02/2003 | EP1296982A1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296958A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP1228069B1 Bicyclic and tricyclic heteroaromatic compounds |
| 04/02/2003 | EP1147109B1 Novel cationic oxidation bases, their use for oxidative dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1081149B1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVES |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0675887B1 Antiallergic triazolobenzazepine derivatives |
| 04/02/2003 | EP0557526B1 Pyrroloazepine compound |
| 04/02/2003 | EP0551527B1 Pyrroloazepine derivative |
| 04/02/2003 | CN1407986A Novel imidazotriazinones and the use thereof |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1406940A Chlorophyll chromium and preparation and use thereof |
| 04/02/2003 | CN1406939A Preparation of Xibo ketone |
| 04/02/2003 | CN1104433C Fungicidal trifluoromethylakylamino-triazolopyrimidines |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104431C Resolution of [R,S]-2-(methoxyimido)-2-(1-azebicyclic [2,2,2] octa-3-radical) acetonitrile |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541628 Solvent-free condensation of an aldehyde with a pyrrole derivative to form corroles, salts or complexes |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541473 Resorcinol derivatives |
| 04/01/2003 | US6541469 CRF receptor antagonists and methods relating thereto |
| 04/01/2003 | US6541468 Treating Alzheimer's disease by inhibiting in a subject hyperphosphoralation characteristic of Alzheimer's disease by a kinase the compound |
| 04/01/2003 | US6541467 And at P1 have a six-membered heterocyclic ring having two ring nitrogen ring atoms and the remainder of the ring atoms carbon atoms. |
| 04/01/2003 | US6541229 Use for better preservation of red blood cells during storage and increased viability in vivo following transfusion |
| 04/01/2003 | US6541192 Pyrrolotriazole cyan couplers |
| 03/28/2003 | CA2405342A1 Methods of treatment and kits comprising a growth hormone secretagogue |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2003024978A1 Inclusion compound comprising cucurbituril derivatives as host molecule and pharmaceutical composition comprising the same |
| 03/27/2003 | WO2003024973A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024971A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024970A1 Compounds which inhibit the release of inflammatory cytokines |
| 03/27/2003 | WO2003024969A1 Tyrosine kinase inhibitors |
| 03/27/2003 | WO2003024968A1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3-b) pyridazine for the treatment of anxiety and convulsions |
| 03/27/2003 | WO2003024967A2 Indolizines as kinase protein inhibitors |
| 03/27/2003 | WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 03/27/2003 | WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003002553A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/27/2003 | WO2002096318A3 Method for treating glaucoma v |
| 03/27/2003 | WO2002026229A1 Airway mucus secretion inhibitors |
| 03/27/2003 | WO2002014321A9 Use of stat-6 inhibitors as therapeutic agents |
| 03/27/2003 | WO2001090109A9 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| 03/27/2003 | US20030060630 Method for the manufacture of Anagrelide |
| 03/27/2003 | US20030060627 8-Phenyl-6, 9-dihydro-[1,2,4] triazolo[3,4-i]purin-5-one derivatives |
| 03/27/2003 | US20030060476 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration |
| 03/27/2003 | US20030060468 Useful for the treatment of disorders involving the central nervous system such as obsessive-compulsive disorder, depression, anxiety, schizophernia, migraine, sleep or eating disorder, obesity, type II diabetes and epilepsy |
| 03/27/2003 | US20030060467 Substituted pyrazolo(1,5-d)(1,2,4)triazine derivatives, possessing a substitued or nonsubstituted cycloalkyl, phenyl or heteroaryl substituent at 7-position, an alkyl at 4-position, substituted alkoxy at 2-position; antianxiolytic |
| 03/27/2003 | US20030060465 Such as 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid morpholinocarbonyloxyethyl ester; for reducing gastrointestinal side effects |
| 03/27/2003 | US20030060462 Therapeutic compounds |
| 03/27/2003 | US20030060458 Indoles and indolines having 5-HT activity |
| 03/27/2003 | US20030059369 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 03/27/2003 | US20030059097 Fluoroscopic registration artifact with optical and/or magnetic markers |
| 03/27/2003 | CA2466243A1 Indolizines as kinase protein inhibitors |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2461073A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | CA2461072A1 Compounds which inhibit the release of inflammatory cytokines |
| 03/27/2003 | CA2461071A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | CA2460445A1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3-b) pyridazine for the treatment of anxiety and convulsions |
| 03/27/2003 | CA2460151A1 Cytokine receptor |
| 03/27/2003 | CA2423945A1 Restrainers of airway mucus secretion |
| 03/26/2003 | EP1295885A1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives |
| 03/26/2003 | EP1295884A1 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives |
| 03/26/2003 | EP1295878A1 Novel pyrazinone derivatives |
| 03/26/2003 | EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 03/26/2003 | EP1294823A1 Double-spiro organic compounds and electroluminescent devices |
| 03/26/2003 | EP1294726A2 Improvements in and relating to chromophores |
| 03/26/2003 | EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 03/26/2003 | EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 03/26/2003 | EP1294723A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 03/26/2003 | EP1294719A1 Melanocortin receptor ligands |
| 03/26/2003 | EP1294718A2 6,5-fused bicyclic heterocycles |
| 03/26/2003 | EP1294702A1 Benzodiazepine derivatives as app modulators |
| 03/26/2003 | EP1294700A2 Benzhydryl derivatives |
| 03/26/2003 | EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents |
| 03/26/2003 | EP1294684A2 THROMBIN OR FACTOR Xa INHIBITORS |
| 03/26/2003 | EP1208102B1 Synthesis of a substituted pyrazolopyrimidine |
| 03/26/2003 | EP1066292B1 Metallocorrinoids as biologically compatible carriers of pharmacological agents |
| 03/26/2003 | CN1406238A A novel crystalline form of N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl]-L-glutamic acid and process therefor |
| 03/26/2003 | CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 03/26/2003 | CN1405144A 由海龙科动物提取的海龙素及其制法和用途 Dragon species extracted by Dragon hormone preparation and use |
| 03/26/2003 | CN1103775C Vitronectin receptor antagonists, their preparation and use |